Effect of retinoic acid in experimental diabetic nephropathy (Q40490436)

21 September 2017

Effect of retinoic acid in experimental diabetic nephropathy (English)

1 reference

21 September 2017

1 reference

Sang-Youb Han

1

1 reference

21 September 2017

Gyeong-A So

2

1 reference

21 September 2017

Yi-Hwa Jee

3

1 reference

21 September 2017

Kum-Hyun Han

4

1 reference

21 September 2017

Young-Sun Kang

5

1 reference

21 September 2017

Hyoung-Kyu Kim

6

1 reference

21 September 2017

Shin-Wook Kang

7

1 reference

21 September 2017

Dae-Suk Han

8

1 reference

21 September 2017

Jee-Young Han

9

1 reference

21 September 2017

Dae-Ryong Cha

10

1 reference

21 September 2017

1 December 2004

1 reference

Immunology & Cell Biology

21 September 2017

1 reference

21 September 2017

82

1 reference

21 September 2017

6

1 reference

21 September 2017

568-576

1 reference

Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.

21 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2004.01287.X

Expression of functional CCR and CXCR chemokine receptors in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2004.01287.X

Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2004.01287.X

Effects of vitamin A and insulin on the antioxidative state of diabetic rat heart: a comparison study with combination treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2004.01287.X

Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2004.01287.X

Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2004.01287.X

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2004.01287.X

Vitamin A, retinol binding protein and lipids in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2004.01287.X

Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2004.01287.X

Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2004.01287.X

Retinoid receptor-specific agonists alleviate experimental glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2004.01287.X

Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2004.01287.X

10.1111/J.1440-1711.2004.01287.X

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference